arrow
D

Dalia Baršytė-Lovejoy

University of Toronto
H指数:53
被引数:1.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

PRMT7 restricts CD8+ T cells expansion via the NF-ΚB pathway

PRMT7通过NF-ΚB通路限制CD8+ T细胞扩增

2026-09-060
OA
ABHD2 activity is not required for the non-genomic action of progesterone on human sperm

ABHD2活性并非孕酮对人类精子非基因组作用所必需

2026-05-290
OA
OICR-41103 as a chemical probe for the DCAF1 WD40 domain

OICR-41103 作为 DCAF1 WD40 结构域的化学探针

2025-07-190
OAAI
PRMT5 promotes full-length HTT expression by repressing multiple proximal intronic polyadenylation sites

PRMT5通过抑制多个近端内含子多聚腺苷酸化位点来促进全长HTT的表达。

2025-04-300
OA
Recruitment of FBXO22 for targeted degradation of NSD2

招募FBXO22靶向降解NSD2

2024-07-047
PRE
A chemical probe to modulate human GID4 Pro/N-degron interactions
2024-05-214
PRE
Chemical tools for the Gid4 subunit of the human E3 ligase C-terminal to LisH (CTLH) degradation complex
2024-01-013
OA
Development of HC-258, a Covalent Acrylamide TEAD Inhibitor That Reduces Gene Expression and Cell Migration

HC-258的开发,一种共价丙烯酰胺TEAD抑制剂,可减少基因表达和细胞迁移

2023-11-306
PRE
Discovery and Characterization of a Chemical Probe Targeting the Zinc-Finger Ubiquitin-Binding Domain of HDAC6
2023-07-273
OAAI
Discovery of a Potent and Selective Targeted NSD2 Degrader for the Reduction of H3K36me2

发现一种有效且选择性的靶向NSD2降解剂,用于还原H3K36me2

2023-03-2825
PRE
Discovery of Nanomolar DCAF1 Small Molecule Ligands
2023-03-2220
OAAI
Reference compounds for characterizing cellular injury in high-content cellular morphology assays
2023-03-1310
OAAI
Discovery and Characterization of BAY-805, a Potent and Selective Inhibitor of Ubiquitin-Specific Protease USP21
2023-02-207
OAAI